期刊文献+

个体和社会功能量表中文版在抑郁障碍患者中的信效度 被引量:44

The reliability and validity of Chinese version of Personal and Social Performance Scale (PSP) in patients with major depressive disorder(MDD)
在线阅读 下载PDF
导出
摘要 目的:考察个体和社会功能量表中文版(Chinese version of the Personal and Social Performancescale,PSP-CHN)在抑郁障碍患者中的信度和效度。方法:收集74例符合《精神障碍诊断和统计手册》第四版(Diagnostic and Statistical Mannual of Mental Disorders,Fourth Edition,test revision,DSM-IV-TR)抑郁障碍诊断标准的门诊或住院患者,其中6例参加了研究者之间一致性培训,68例(急性期42例,稳定期26例)进行了大体功能量表(Global Assessment of Functioning Scale,GAF))、Hamilton抑郁量表17项(Ham-ilton Depression Rating Scale17items,HAMD-17)和PSP-CHN检查,分析PSP-CHN量表评估抑郁障碍患者的内部一致性、PSP-CHN与GAF的一致性(效标效度)以及与患者疾病严重度的相关性(关联效度),32例患者在首次PSP-CHN评估后的5~7天内,由另一名研究者对其进行第2次检查,评价PSP-CHN在抑郁障碍患者中的重测信度。26例HAMD17评分>17分的患者,接受标准化治疗8周后,评估HAMD17评分和PSP-CHN的评分变化。结果:PSP-CHN量表的内部一致性Cronbachα系数为0.71,PSP-CHN总分的研究者之间一致性Kappa值为0.82(ICC=0.94),重测一致性ICC=0.90。PSP-CHN总分与GAF总分呈正相关(r=0.95,P<0.001),与HAMD-17总分负相关(r=-0.54),急性期和稳定期与PSP-CHN总分相关的抑郁因子不同。结论:个体和社会功能量表中文版可以评价抑郁症患者的个体和社会功能,但是总体信度低于在精神分裂症患者中的评估。 Objective: To evaluate the reliability and validity of the Chinese version of the Personal and Social Performance Scale ( PSP-CHN) in patients with major depressive disorder( MDD ). Method: Seventy-four outpatients and in-patients meeting the Diagnostic and Statistical Mannual of Mental Disorders, Fourth Edition' test revision (DSM-IV-TR) criteria for major depressive disorder were entered in the study. The Global Assessment of Functiomng Scale (OAF) was regarded as the "gold standard "to investigate the validity of FSF-CHN. The Hamilton Depression Rating Scale 17 items ( HAMD-17) was used to assess the severity of disease to explore the correlative validity. Five to seven days after the first PSP-CHN interview, the second PSP-CHN was evaluated by another investigator to assess the test-retest reliability in the patients with MDD. Six subjects were included the inter-rater reliability training. Thirty-two patients with HAMD-17 score more than 17 were followed up for 8 weeks of standardized pharmacotherapy, by the end of 8 weeks, the HAMD-17 and PSP-CHN were reassessed, to explore the sensitivity of PSP-CHN in patients with MDD. Results: The internal consistency ( Cronbach's alpha =0. 71 ) and the inter-rater reliability ( Kappa = 0. 82, ICC = 0. 94 for PSP-CHN total score ) was good. The test-retest reliability was high (ICC = 0. 90) . The scale showed good construct validity with statistically significant correlations with the GAF. The PSP-CHN score had a good negative correlation with the HAMD-17 total score. In the acute phase and stable phase, the factors correlation with PSP total score were different. Conclusion: The Chinese version of the PSPCHN can be used to assess the personal and social functions of patients with MDD, but the total reliability is not so well as that of assessment of schizophrenia.
出处 《中国心理卫生杂志》 CSSCI CSCD 北大核心 2010年第7期481-485,共5页 Chinese Mental Health Journal
关键词 社会功能 抑郁障碍 个人和社会功能量表 信度 效度 social function depression Chinese Version of the Personal and Social Performance Scale ( PSP-CHN ) reliability validity
  • 相关文献

参考文献15

  • 1Paykel ES,Weissman MM,Prusoff BA,et al.Dimensions of social adjustment in depressed women[J].J Nerv Ment Dis,1971,152:158-172.
  • 2Broadlead WE,Blazer DG,George LK,et al.Depression,disability days,and days lost from work in aprospecfive epidemiologic stuvey[J].JAMA,1990,264:2524-2528.
  • 3Johnson J,Weissman MM,Klerman GL.Service utilization and social morbidity associated with depressive symptoms in the community[J].JAMA,1992,267:1478-1483.
  • 4Sherbourne CD,Wells KB,Hays RD,et al.Subthreshold depression and depressive disorder:clinical characteristics of general medical and mental health specialty outpatients[J].Am J Psychiatry,1994,151:1777-1784.
  • 5The World Health Report 2004.Annex Table 3 Burden of disease in DALYs by cause,sex and mortality stratum in WHO regions,estimate for 2002[R].Geneva:World Health Organization,2000.
  • 6Kennedy N,Foy K,Sherazi R,et al.Long-term social functioning after depression treated by psychiatrists:a review[J].Bipolar Disord,2007,9:25-37.
  • 7Bech P.Social functioning:Should it become an endpoint in trials of antidepressants?[J].CNS Drugs,2005,19(4):313-324.
  • 8Morosini PL,Magliano L,Brambilla L,et al.Development,reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning[J].Acta Psychiatr Scand,2000,101:323-329.
  • 9Bums T,Patrick D.Social functioning as an outcome measure in schizophrenia studies[J].Acta Psychiatr Scand,2007,116:403-418.
  • 10Juckel G,Schaub D,Fuchs N,et al.Validation of the Personal and Social Performance (PSP) Scale in a German sample of acutely ill patients with schizophrenia[J].Schizophr Res,2008,104:287-293.

二级参考文献10

  • 1Hwu HG,Tan H,Chen CC,et al.Negative symptoms at discharge and outcome in schizophrenia[].Br J Psychi-atry.1995
  • 2Burns T,,Patrick D.Social functioning as an outcome measure in schizophrenia studies[].Acta PsychiatrScand.2007
  • 3Juckel G,Morosini PL.The new approach:psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia[].Current Opinion in Psychiatry.2008
  • 4Juckel G,Schaub D,Fuchs N,et al.Validation of the Personal and Social Performance(PSP)Scale in a German sample of acutely ill patients with schizophrenia[].Schizophrenia Research.2008
  • 5Patrick D,Morosini PL,Rothman M.Reliability,validity and sensitivity to change of the Personal and Social Per-formance scale in patients with acute schizophrenia[].International Journal of Neuropsychiatry.2006
  • 6Nasrallah H,Morosini P,Gagnon DD.Personal and So-cial performance scale in patients with stable schizophrenia[].Psychiatry Research.
  • 7Kane J,Canas F,Kramer M,et al.Treatment of schizo-phrenia with paliperidone extended-release tablets:a6-week placebo-controlled trial[].Schizophrenia Research.2007
  • 8Morosini,P. L.,Magliano,L.,Brambilla,L.,Ugolini,S.,Pioli,R.Development, reliability and acceptability of a new version of the DSM-IV social and occupational functioning assessment scale (SOFAS) to assess routine social functioning[].Acta Psychiatrica Scandinavica.2000
  • 9Kramer,M,Simpson,G,Maciulis,V,Kushner,S,Vijapurkar,U,Lim,P,Eerdekens,M.Paliperidone extended-release tablets for prevention of symptom recurrence in patients with schizophrenia: a randomized, double-blind, placebo-controlled study[].Journal of Clinical Psychopharmacology.2007
  • 10MARDER SR,KRAMER M,FORD L,et al.Efficacy and safetyof paliperidone extended-release tablets:Results of a 6-week,randomized,placebo controlled study[].Biological Psychiatry.2007

共引文献212

同被引文献459

引证文献44

二级引证文献280

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部